Guiling Chen
Shulan (Hangzhou) Hospital
3
3
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
lanjuan li
Shulan (Hangzhou) Hospital
Shared therapeutic areas:
Worked with same sponsors:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Matthew J Memoli, M.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Shared therapeutic areas:
Helen Heslop, MD
Baylor College of Medicine
Shared therapeutic areas:
Yuwen Su
Sir Run Run Hosipital Nanjing Medical University
Shared therapeutic areas:
Worked with same sponsors:
Xiaolong Qi, MD
LanZhou University
Shared therapeutic areas:
Worked with same sponsors:
Toshimitsu Tokimoto
Astrazeneca KK
Shared therapeutic areas:
Wenhong Zhang, MD
Huashan Hospital
Shared therapeutic areas:
Mitchell S Cairo, MD
New York Medical College
Shared therapeutic areas:
Shai a Efrati, MD
Asaf-Harofhe MC
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Older Adults.
A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Adults Aged 18 -59 Years.
All 3 trials loaded